Factors associated with missed and delayed DTP3 vaccination in children aged 12 - 59 months in two communities in South Africa, 2012 - 2013.
Journal
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
ISSN: 2078-5135
Titre abrégé: S Afr Med J
Pays: South Africa
ID NLM: 0404520
Informations de publication
Date de publication:
26 Jul 2019
26 Jul 2019
Historique:
received:
26
07
2019
entrez:
29
8
2019
pubmed:
29
8
2019
medline:
27
12
2019
Statut:
epublish
Résumé
Although immunisation services are available to all children in South Africa (SA), many children miss or have delays in receiving vaccines. There are limited data on factors associated with missed or delayed vaccination in children in this setting. To assess vaccination coverage and factors associated with missed and delayed diphtheria-tetanus-pertussis vaccine third dose (DTP3) vaccination in children aged 12 - 59 months in two SA communities. We used data from household-level healthcare utilisation surveys conducted in Soweto in 2012 and in Pietermaritzburg in 2013. Information on vaccination status was recorded from the Road to Health cards or vaccination history from clinics for children aged <5 years. Factors associated with missed or delayed DTP3 vaccination were assessed using unconditional logistic regression. Of a total of 847 eligible children aged 12 - 59 months, 716 had available vaccination information. Overall DTP3 vaccination coverage was high for both sites: 90.6% in Pietermaritzburg and 93.9% in Soweto. However, 32.6% and 25.2% of DTP3 vaccinations were delayed (received after 18 weeks of age) in Pietermaritzburg and Soweto, respectively. The median delay for DTP3 vaccinations was 4.7 weeks (interquartile range 1.7 - 23.0). Factors associated with delayed DTP3 vaccination included being born in 2010 (adjusted odds ratio (aOR) 3.0, 95% confidence interval (CI) 1.4 - 6.3) or 2011 (aOR 2.7, 95% CI 1.3 - 5.7) compared with being born in 2008, probably due to vaccine shortages; a low level of education of the primary caregiver, with children whose caregivers had completed secondary education having lower odds of delayed vaccination (aOR 0.5, 95% CI 0.3 - 0.9) than children whose caregivers only had primary education; and maternal HIV status, with unknown status (aOR 3.5, 95% CI 1.6 - 7.6) associated with higher odds of delay than positive status. Factors associated with missed DTP3 vaccination (not vaccinated by 12 months of age) included two or more children aged <5 years in a household (aOR 2.4, 95% CI 1.2 - 4.9) compared with one child, and household monthly income <ZAR500 (aOR 3.4, 95% CI 1.1 - 11.4) compared with ≥ZAR2 000. Despite high overall DTP3 coverage observed in two communities, many vaccinations were delayed. Vulnerable groups identified in this study should be targeted with improved vaccination services to enhance uptake and timeliness of vaccination.
Sections du résumé
BACKGROUND
BACKGROUND
Although immunisation services are available to all children in South Africa (SA), many children miss or have delays in receiving vaccines. There are limited data on factors associated with missed or delayed vaccination in children in this setting.
OBJECTIVES
OBJECTIVE
To assess vaccination coverage and factors associated with missed and delayed diphtheria-tetanus-pertussis vaccine third dose (DTP3) vaccination in children aged 12 - 59 months in two SA communities.
METHODS
METHODS
We used data from household-level healthcare utilisation surveys conducted in Soweto in 2012 and in Pietermaritzburg in 2013. Information on vaccination status was recorded from the Road to Health cards or vaccination history from clinics for children aged <5 years. Factors associated with missed or delayed DTP3 vaccination were assessed using unconditional logistic regression.
RESULTS
RESULTS
Of a total of 847 eligible children aged 12 - 59 months, 716 had available vaccination information. Overall DTP3 vaccination coverage was high for both sites: 90.6% in Pietermaritzburg and 93.9% in Soweto. However, 32.6% and 25.2% of DTP3 vaccinations were delayed (received after 18 weeks of age) in Pietermaritzburg and Soweto, respectively. The median delay for DTP3 vaccinations was 4.7 weeks (interquartile range 1.7 - 23.0). Factors associated with delayed DTP3 vaccination included being born in 2010 (adjusted odds ratio (aOR) 3.0, 95% confidence interval (CI) 1.4 - 6.3) or 2011 (aOR 2.7, 95% CI 1.3 - 5.7) compared with being born in 2008, probably due to vaccine shortages; a low level of education of the primary caregiver, with children whose caregivers had completed secondary education having lower odds of delayed vaccination (aOR 0.5, 95% CI 0.3 - 0.9) than children whose caregivers only had primary education; and maternal HIV status, with unknown status (aOR 3.5, 95% CI 1.6 - 7.6) associated with higher odds of delay than positive status. Factors associated with missed DTP3 vaccination (not vaccinated by 12 months of age) included two or more children aged <5 years in a household (aOR 2.4, 95% CI 1.2 - 4.9) compared with one child, and household monthly income <ZAR500 (aOR 3.4, 95% CI 1.1 - 11.4) compared with ≥ZAR2 000.
CONCLUSIONS
CONCLUSIONS
Despite high overall DTP3 coverage observed in two communities, many vaccinations were delayed. Vulnerable groups identified in this study should be targeted with improved vaccination services to enhance uptake and timeliness of vaccination.
Identifiants
pubmed: 31456549
doi: 10.7196/SAMJ.2019.v109i8.13244
pmc: PMC7804387
mid: NIHMS1659074
doi:
Substances chimiques
Diphtheria-Tetanus-Pertussis Vaccine
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
562-569Subventions
Organisme : NCIRD CDC HHS
ID : U51 IP000155
Pays : United States
Organisme : NCIRD CDC HHS
ID : U51 IP000528
Pays : United States
Références
S Afr Med J. 2016 Dec 21;107(1):52-55
pubmed: 28112092
BMC Public Health. 2011 May 27;11:404
pubmed: 21619642
Vaccine. 2014 Jun 12;32(28):3533-9
pubmed: 24814558
Vaccine. 2014 Sep 22;32(42):5514-9
pubmed: 25132336
Vaccine. 2010 Feb 17;28(7):1861-9
pubmed: 20006570
Bull World Health Organ. 2009 Jul;87(7):535-41
pubmed: 19649368
Lancet. 2009 May 2;373(9674):1543-9
pubmed: 19303633
Hum Vaccin Immunother. 2014;10(5):1408-15
pubmed: 24584000
BMC Public Health. 2014 May 17;14:464
pubmed: 24884641
PLoS One. 2012;7(5):e37905
pubmed: 22662247
Vaccine. 2012 Dec 14;30(52):7588-93
pubmed: 23102973
Vaccine. 2009 Feb 25;27(9):1426-32
pubmed: 19146901
Lancet. 2005 Jul 9-15;366(9480):144-50
pubmed: 16005337
BMC Pediatr. 2015 Apr 01;15:31
pubmed: 25886255
J Trop Pediatr. 2012 Apr;58(2):133-8
pubmed: 21742766
Lancet. 2012 Jun 9;379(9832):2151-61
pubmed: 22579125
PLoS One. 2016 May 06;11(5):e0154997
pubmed: 27152612
J Epidemiol Community Health. 2012 Jul;66(7):e14
pubmed: 21551179
Vaccine. 2015 Nov 27;33(48):6778-85
pubmed: 26482146
Health Policy Plan. 1995 Sep;10(3):304-12
pubmed: 10151848
MMWR Morb Mortal Wkly Rep. 2016 Nov 18;65(45):1270-1273
pubmed: 27855146
S Afr Med J. 2008 Jan;98(1):41-5
pubmed: 18270640
Int Health. 2013 Jun;5(2):139-47
pubmed: 24030114
Trop Med Int Health. 2009 Nov;14(11):1383-93
pubmed: 19737375
Vaccine. 2013 Dec 17;32(1):96-102
pubmed: 24183978
Influenza Other Respir Viruses. 2016 Sep;10(5):421-8
pubmed: 26987756